Abeona Therapeutics Inc. (ABEO) stock
ABEONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/3028% below fair value
$2.60+0.00 (0.00%)
Close on Nov 17, 2026Market cap $148.68MP/E –Yield –
Abeona Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Abeona Therapeutics's price to sales ratio was 5.2× on Nov 11, 2026, against 52.3× a year earlier. Over the last 5 years it ranged from 1.9× to 465.0×, with a median of 53.3×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 5.2× | −26.2 |
| 2024 | Apr 30, 2024 | 31.4× | −7.1 |
| 2023 | Apr 28, 2023 | 38.5× | +21.5 |
| 2021 | Apr 30, 2021 | 17.0× | −36.3 |
| 2019 | Oct 31, 2019 | 53.3× | −69.4 |
| 2018 | Dec 31, 2018 | 122.7× | −240.0 |
| 2017 | Jul 31, 2017 | 362.7× | +174.6 |
| 2016 | Dec 30, 2016 | 188.2× | +186.2 |
| 2015 | Jan 30, 2015 | 1.9× | −0.2 |
| 2014 | Dec 31, 2014 | 2.1× | −0.1 |
| 2013 | Dec 31, 2013 | 2.2× | +0.7 |
| 2012 | Dec 31, 2012 | 1.5× | – |
See a number that looks wrong?